Study to Evaluate the Performance and Safety of ATF Implants and Lapé Médical Devices Implanted During Hip Arthroplasty

NCT ID: NCT05044767

Last Updated: 2023-02-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

4500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-06-07

Study Completion Date

2032-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Observational and prospective multicenter study to evaluate the long-term (10 years) performance and safety (10 years) of ATF Implants and Lapé Médical devices implanted during total hip arthroplasty or hemiarthroplasty.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Observational and prospective multicenter study to evaluate the long-term (10 years) performance and safety (10 years) of ATF Implants and Lapé Médical devices implanted during total hip arthroplasty or hemiarthroplasty.

The post-market clinical follow-up study to be conducted by ATF Implants following this plan aims to collect data from the follow-up of patients before and after hip replacement surgery with implants manufactured by ATF Implants and Lapé médical. In current practice, the surgeon-investigator evaluates the patient pre- and post-operatively according to predefined criteria used in orthopedic surgery and more particularly in hp replacement surgery. Complications and adverse effects observed are also recorded.

The main objective is to gather clinical evidence to evaluate the survival rate of ATP Implants and Lapé médical hip prostheses over the long-term, namely 10 years.

The secondary objectives are to evaluate the performance and safety of the prostheses over the same period (i.e. 10 years), as well as to obtain feedback on the performance /intended use and safety of the surgical instruments required for implant placement.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arthroplasty, Hip, Replacement

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

total hip arthroplasty

hip replacement surgery

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

hemiarthroplasty

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female indicated for hip replacement surgery with hip prosthesis manufactured by ATF Implants and/or Lapé médical;

There are different indications for hip replacement surgery. The main ones are listed below:

* Dysplasia
* Primary Coxarthrosis
* Secondary Coxarthrosis
* Perthes disease
* Epiphysiolysis
* Ankylosing spondylitis
* Trochanteric bursitis
* Arthritis
* Degenerative arthritis
* Post-traumatic arthritis
* Rheumatoid arthritis
* Femoral neck fracture
* Osteonecrosis
* Revision

Depending on the specificities of the devices (size, absence/presence of a coating, material), indications may vary. This information can be found in the instruction for use. It is the surgeon's responsibility to select the most appropriate prosthesis for a given patient according to the patient's medical records and the instruction for use in force at the time of the procedure accompanying the medical device.

Exclusion Criteria

* There are various contraindications for hip arthroplasty. The main ones are listed below:

* An acute or chronic, local or systemic infection
* Severe muscular, neurological or vascular deficiency compromising the affected extremity
* A bone defect or insufficient bone quality that may compromise the stability of the implant
* Any concomitant disease (dysplastic coxarthrosis with extreme coxa valga, short neck and severe varus) that may affect the function of the implant
* Sensitivity to the material (allergy) Depending on the specificities of the devices (size, absence/presence of a coating, material), contraindications may vary. This information can be found in the instruction for use of the devices.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

ATF Implants

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Philippe Laffargue, Pr

Role: PRINCIPAL_INVESTIGATOR

Clinique du Croisé Laroche

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Bordeaux - Hôpital Pellegrin

Bordeaux, , France

Site Status NOT_YET_RECRUITING

Clinique des Cèdres

Cornebarrieu, , France

Site Status NOT_YET_RECRUITING

Centre Ostéo-Articulaire des Cèdres

Échirolles, , France

Site Status RECRUITING

Hôpital privé Drôme Ardèche

Guilherand-Granges, , France

Site Status NOT_YET_RECRUITING

Clinique du Croisé Laroche

Marcq-en-Barœul, , France

Site Status RECRUITING

Polyclinique Saint George

Nice, , France

Site Status NOT_YET_RECRUITING

Groupe Hospitalier Diaconesses Croix Saint-Simon

Paris, , France

Site Status RECRUITING

CHU de Poitiers

Poitiers, , France

Site Status RECRUITING

Clinique de l'Atlantique

Puilboreau, , France

Site Status NOT_YET_RECRUITING

CHU St Etienne, Hôpital Nord

Saint-Etienne, , France

Site Status NOT_YET_RECRUITING

Polyclinique Sainte Thérèse

Sète, , France

Site Status RECRUITING

Clinique de l'Orangerie

Strasbourg, , France

Site Status RECRUITING

Hôpital privé du Vert Galant

Tremblay-en-France, , France

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Philippe Laffargue, Pr

Role: CONTACT

891650494 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Vincent Souillac

Role: primary

556795544 ext. +33

Jonathan Hourtal

Role: primary

562133131 ext. +33

Jean-Claude Panisset

Role: primary

476481485 ext. +33

Richard Philippe

Role: primary

475823180 ext. +33

Philippe Laffargue

Role: primary

891650494 ext. +33

Hervé Ovadia

Role: primary

493817150 ext. +33

Simon Marmor

Role: primary

144641600 ext. +33

Pierre Bouget

Role: primary

549444492 ext. +33

Cédric Bouquet

Role: primary

536288500 ext. +33

Frédéric Farizon

Role: primary

477120372 ext. +33

François Lozach

Role: primary

467536286 ext. +33

David Dagrenat

Role: primary

388360088 ext. +33

Faouzi Madi

Role: primary

826309393 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PEPS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Medacta Quadra-P Anteverted Study
NCT05460715 ACTIVE_NOT_RECRUITING
Avenir® Cemented Hip Stem - PMCF
NCT03396224 ACTIVE_NOT_RECRUITING